What 5 Analyst Ratings Have To Say About Praxis Precision Medicine
Portfolio Pulse from Benzinga Insights
Praxis Precision Medicine (NASDAQ:PRAX) has received 4 bullish and 1 indifferent analyst ratings in the last quarter. The average price target is $8.6, implying an upside from the current price of $1.04. However, this average has decreased by 42.67% from the previous average price target of $15.00.
August 10, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Praxis Precision Medicine has received mostly bullish ratings from analysts, with a potential upside based on the average price target.
The majority of analyst ratings for Praxis Precision Medicine are bullish, indicating a positive outlook for the stock. The average price target suggests a significant potential upside from the current price, which could attract investors and drive the stock price up. However, the decrease in the average price target could indicate a less optimistic view compared to previous assessments.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100